Patents by Inventor Barry A. Morgan

Barry A. Morgan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5021765
    Abstract: A security system suitable for monitoring the presence of the occupants of a vessel such as a sailing yacht has two receivers at fixed locations on the yacht for receiving signals from one of a number of transmitters each worn by a respective crew member. The receivers are connected to a detector having a comparator triggered when a predetermined relative signal strength is generated by the receivers indicating the presence of a transmitter in an "unsafe" region acting to cause triggering of an alarm and automatic ejection of a life buoy or other life saving equipment.
    Type: Grant
    Filed: May 1, 1989
    Date of Patent: June 4, 1991
    Assignee: Transaqua Technology Limited
    Inventor: Barry A. Morgan
  • Patent number: 4839465
    Abstract: Di(D-tryptophyl and/or tetrahydropyridoindolylcarbonyl)-containing peptide amides useful as Substance P agonists and/or antagonists and as antihypertensives and/or analgesics and a process for preparing them are disclosed.
    Type: Grant
    Filed: January 20, 1987
    Date of Patent: June 13, 1989
    Assignee: Sterling Drug Inc.
    Inventors: Jasbir Singh, Barry A. Morgan
  • Patent number: 4658013
    Abstract: A genus of tripeptide amides and fifteen species thereof of Examples 4-18, which are useful as analgesics and/or opiate antagonists, three processes for preparation thereof, pharmaceutical compositions thereof, and the three tripeptide amide species of Examples 1-3, which are not within the genus and are useful as analgesics and/or opiate antagonists, are disclosed.
    Type: Grant
    Filed: February 22, 1983
    Date of Patent: April 14, 1987
    Assignee: Sterling Drug Inc.
    Inventor: Barry A. Morgan
  • Patent number: 4533655
    Abstract: A genus of dipeptide amides including as the preferred subgenus the dipeptide amides having the structural formula R.sub.1 TyrR.sub.2 D-AlaNHR.sub.4 wherein R.sub.1 and R.sub.2 are each hydrogen or alkyl provided that at least one of them is other than hydrogen and R.sub.4 is phenylalkyl or substituted-phenylalkyl are prepared by condensing the dipeptide with the amine or the amino acid with the amino acid amide and are useful as analgesics.
    Type: Grant
    Filed: September 24, 1982
    Date of Patent: August 6, 1985
    Assignee: Sterling Drug Inc.
    Inventor: Barry A. Morgan
  • Patent number: 4533657
    Abstract: A genus of dipeptide amides including as the preferred subgenus the dipeptide amides having the structural formula HTyrD-AlaNR.sub.2 R.sub.3 wherein R.sub.2 is phenylalkyl or substituted-phenylalkyl and R.sub.3 is hydrogen, alkyl, phenylalkyl, substituted-phenylalkyl or X-alkyl wherein X is an electronegative moiety are prepared by condensing the dipeptide with the amine or the amino acid with the amino acid amide and are useful as analgesics.
    Type: Grant
    Filed: September 24, 1982
    Date of Patent: August 6, 1985
    Assignee: Sterling Drug Inc.
    Inventor: Barry A. Morgan
  • Patent number: 4472305
    Abstract: N-Terminal L-prolyl or D-prolyl hexapeptide amides useful as Substance P agonists and/or antagonists and as analgesics and/or antihypertensives and a process for preparing them are disclosed.
    Type: Grant
    Filed: May 17, 1983
    Date of Patent: September 18, 1984
    Assignee: Sterling Drug Inc.
    Inventors: Philip E. Hansen, Barry A. Morgan
  • Patent number: 4454120
    Abstract: A genus of dipeptide amides including as the preferred subgenus the dipeptide amides having the structural formula R.sub.1 TyrR.sub.2 D-Q-NR.sub.4 R.sub.5 wherein Q is Met, Met(O), Gln or Ser, R.sub.1 and R.sub.2 are each hydrogen or alkyl, R.sub.4 is phenylalkyl or substituted-phenylalkyl and R.sub.5 is hydrogen, alkyl, phenylalkyl, substituted-phenylalkyl or X-alkyl wherein X is an electronegative group are prepared by condensing the dipeptide with the amine or the amino acid with the amino acid amide and are useful as analgesics.
    Type: Grant
    Filed: September 24, 1982
    Date of Patent: June 12, 1984
    Assignee: Sterling Drug Inc.
    Inventor: Barry A. Morgan
  • Patent number: 4450155
    Abstract: A genus of dipeptide amides including as the preferred subgenus the dipeptide amides having the structural formula R.sub.1 TyrProNR.sub.4 R.sub.5 wherein R.sub.1 is hydrogen or alkyl, R.sub.4 is phenylalkyl or substituted-phenylalkyl and R.sub.5 is hydrogen, alkyl, phenylalkyl or substituted-phenylalkyl are prepared by condensing the dipeptide with the amine or the amino acid with the amino acid amide and are useful as analgesics.
    Type: Grant
    Filed: September 24, 1982
    Date of Patent: May 22, 1984
    Assignee: Sterling Drug Inc.
    Inventor: Barry A. Morgan
  • Patent number: 4199568
    Abstract: Tetrapeptide amides of the formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, A and B represent certain specified substituent groups and where n is 2-5, p is 1-5 and r is 1 or 2. The compounds exhibit pharmacological activity when tested in the transmurally stimulating guinea pig ileum preparation indicating their affinity for opiate receptor sites and they may therefore be used in man for those conditions where an opiate-like effect is indicated.
    Type: Grant
    Filed: September 13, 1978
    Date of Patent: April 22, 1980
    Assignee: Reckitt & Colman Products Limited
    Inventors: Michael J. Rance, Balraj K. Handa, Barry A. Morgan
  • Patent number: 4178371
    Abstract: Tetrapeptide amides of the formula ##STR1## wherein R.sup.1, R.sup.8, R.sup.x, B and D represent certain specified substituent groups. The compounds exhibit pharmacological activity when tested in vitro in the transmurally stimulated guinea pig ileum preparation indicating their affinity for opiate receptor sites, and also in vivo tests, with intravenous administration, indicating their analgesic effects, and hence their utility as analgesic agents.
    Type: Grant
    Filed: November 27, 1978
    Date of Patent: December 11, 1979
    Assignee: Reckitt & Colman Products Limited
    Inventor: Barry A. Morgan
  • Patent number: 4060603
    Abstract: Compounds of the formula ##STR1## wherein R, R.sup.1, R.sup.2, R.sup.3 and R.sup.4 represent certain specified substituent groups. The compounds exhibit activity in the reserpine induced hypothermia test.
    Type: Grant
    Filed: February 20, 1976
    Date of Patent: November 29, 1977
    Assignee: Reckitt & Colman Products Limited
    Inventors: Barry A. Morgan, Derek J. Schafer